Buserelin

Amber-G

Brand Name(s):Suprefact

Indication:Prostatic Cancer (Advanced); endometriosis

Rationale:

Considered:Sep-06

Review Date:Jul-23

Comments:
Initiation of therapy: is most conveniently carried out in hospital; 0.5 ml Suprefact injection should be injected subcutaneously at 8 hourly intervals for 7 days.

Maintenance therapy: on the 8th day of treatment the patient is changed to intranasal administration of Suprefact.

Buserelin (Suprefact nasal spray) Summary of Product Characteristics 01/12/2009